Dyskeratosis congenita: a genetic disorder of many faces
- 15 November 2007
- journal article
- review article
- Published by Wiley in Clinical Genetics
- Vol. 73 (2), 103-112
- https://doi.org/10.1111/j.1399-0004.2007.00923.x
Abstract
Dyskeratosis congenita (DC) is an inherited syndrome exhibiting marked clinical and genetic heterogeneity. It is characterized by multiple features including mucocutaneous abnormalities, bone marrow failure and an increased predisposition to cancer. Three genetic subtypes are recognized: X‐linked recessive DC bears mutations in DKC1, the gene encoding dyskerin, a component of H/ACA small nucleolar ribonucleoprotein particles; autosomal dominant (AD) DC has heterozygous mutations in either TERC or TERT, the RNA and enzymatic components of telomerase, respectively, and autosomal recessive DC in which the genes involved remain largely elusive. Disease pathology is believed to be a consequence of chromosome instability because of telomerase deficiency due to mutations in DKC1, TERC and TERT; in patients with DKC1 mutations, defects in ribosomal RNA modification, ribosome biogenesis, translation control or mRNA splicing may also contribute to disease pathogenesis. The involvement of telomerase complex components in X‐linked and AD forms and the presence of short telomeres in DC patients suggest that DC is primarily a disease of defective telomere maintenance. Treatment is variable and complicated by the development of secondary cancers but, being a monogenic disorder, it could potentially be treated by gene therapy. DC overlaps both clinically and genetically with several other diseases including Hoyeraal–Hreidarsson syndrome, aplastic anaemia and myelodysplasia, among others and its underlying telomeric defect has implications for a broader range of biological processes including ageing and many forms of cancer.Keywords
This publication has 67 references indexed in Scilit:
- Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndromeBlood, 2007
- Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantationPediatric Transplantation, 2007
- Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10Human Molecular Genetics, 2007
- Telomerase Mutations in Families with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2007
- Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenitaGenes & Development, 2006
- Mutations inTERT,the Gene for Telomerase Reverse Transcriptase, in Aplastic AnemiaNew England Journal of Medicine, 2005
- Telomerase activity level, but not hTERT mRNA and hTR level, regulates telomere length in telomerase-reconstituted primary fibroblastsExperimental Cell Research, 2004
- Telomeres shorten during ageing of human fibroblastsNature, 1990
- Dyskeratosis congenita with hypoplastic anemia: A stem cell defectAmerican Journal of Hematology, 1985
- HAEMOPOIETIC PROGENITOR CELLS IN DYSKERATOSIS CONGENITABritish Journal of Haematology, 1984